Company news
Dianthus Therapeutics, Inc. news in 2019
Dianthus Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug Conjugate
December 8, 2019
Magenta Therapeutics to Present at the Evercore ISI HealthCONx Conference on Tuesday, December 3rd
November 25, 2019
Magenta Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
November 12, 2019
Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR
November 10, 2019
Magenta Therapeutics to Present New Clinical and Preclinical Data at American Society of Hematology (ASH) Annual Meeting
November 5, 2019
Magenta Therapeutics Appoints Jan Pinkas as Senior Vice President, Head of Translational Sciences and Announces Transition of Chief Scientific Officer
October 15, 2019
Decks in 2019
- Magenta Therapeutics — Investor Presentation (January 2019)
Investor deck · 40 slides · Jan 7, 2019